Inquiry email: info@leader-biogroup.com
Hot Line +86-029-68895030
+86-029-68569961
+86-029-68569962
Fax +86-029-68895030
Product Name: |
RibCys |
Synonyms: |
(1R)-1-[(4R)-4-Carboxythiazolidine-2-yl]-D-erythro-tetritol;(4R)-2-[(1R,2R,3R)-1,2,3,4-Tetrahydroxybutyl]thiazolidine-4-carboxylic acid;(4R)-2-[(1R,2R,3R)-1,2,3,4-Tetrahydroxybutyl]thiazolidine-4α-carboxylic acid;RibCys;D-Ribose-L-cysteine (Mixture of DiastereoMers);D-Ribose-L-cysteine;D-Ribose-L-cysteine(RibCys);4-Thiazolidinecarboxylic acid, 2-[(1R,2R,3R)-1,2,3,4-tetrahydroxybutyl]-, (4R)- |
CAS: |
232617-15-1 |
MF: |
C8H15NO6S |
MW: |
253.27 |
EINECS: |
|
Product Categories: |
|
Mol File: |
232617-15-1.mol |
 |
|
RibCys Chemical Properties |
Boiling point |
654.4±55.0 °C(Predicted) |
density |
1.624±0.06 g/cm3(Predicted) |
pka |
1.97±0.40(Predicted) |
|
RibCys Usage And Synthesis |
Uses |
D-Ribose-L-cysteine is a prodrug of L-cysteine that has potential therapeutic advantage in the inhibition of astrocytoma cell proliferation. D-Ribose-L-cysteine has been shown to protect against aceta minophen-induced hepatic and renal toxicity. |
|
RibCys Preparation Products And Raw materials
|
|